AEON Biopharma Inc
AEON.WS
AEON.WS was delisted on the 26th of April, 2024.
52 hedge funds and large institutions have $5.62M invested in AEON Biopharma Inc in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 8 closing their positions.
1% less capital invested
Capital invested by funds: $5.67M → $5.62M (-$51.3K)
2% less funds holding
Funds holding: 53 → 52 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$10.8K |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$4.67K |
| 3 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$3.37K |
| 4 |
CIM
Cowen Investment Management
New York
|
+$1.01K |
| 5 |
CS
Clear Street
New York
|
+$636 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parallax Volatility Advisers
San Francisco,
California
|
-$11.5K |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$8K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$7K |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$5K |
| 5 |
AGM
Alpine Global Management
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| $7 | +$6 | +144 | New |
|
|
UOC
52
UBS O'Connor
Chicago,
Illinois
| – | -$8K | -112,473 | Closed |
|
|
53
Verition Fund Management
Greenwich,
Connecticut
| – | -$7K | -100,000 | Closed |
|
|
MF
54
Magnetar Financial
Evanston,
Illinois
| – | -$5K | -61,159 | Closed |
|
|
AGM
55
Alpine Global Management
New York
| – | -$3K | -50,100 | Closed |
|
|
LOAMU
56
Lombard Odier Asset Management (USA)
New York
| – | -$3K | -41,666 | Closed |
|
|
ESCM
57
Echo Street Capital Management
New York
| – | -$2K | -33,333 | Closed |
|
58
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1K | -17,009 | Closed |
|
|
TCM
59
Tegean Capital Management
New York
| – | -$1K | -14,000 | Closed |
|
AEON.WS Hedge Fund Activity: Q4 2022 in Review
52 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma Inc (AEON.WS) for Q4 2022, worth a combined $5.62M — down 0.9% from $5.67M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of AEON.WS and 7 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 4 added.
The largest buyer was Cowen and Company, opening a new position worth an estimated $10.8K. The largest seller was Parallax Volatility Advisers, cutting an estimated $11.5K.
- 52 institutional investors held AEON Biopharma Inc (AEON.WS) as of Q4 2022, down from 53 in Q3 2022.
- Funds reported $5.62M of AEON Biopharma Inc stock for Q4 2022, down 0.9% quarter-over-quarter.
- 7 funds opened new AEON Biopharma Inc positions in Q4 2022 and 8 closed out, a net change of -1 holder.
- The largest AEON Biopharma Inc buyer in Q4 2022 was Cowen and Company, an estimated $10.8K added.
- The largest AEON Biopharma Inc seller in Q4 2022 was Parallax Volatility Advisers, an estimated $11.5K sold.
Based on aggregated 13F filings for Q4 2022.